References
1 Vrdoljak E, Sullivan R, Lawler M. Cancer and coronavirus disease 2019; how do we manage cancer optimally
through a public health crisis? Eur J Cancer. 2020; 132:98-99.
2 https://www.hdruk.ac.uk/case-studies/delineating-the-adverse-impacts-of-the-covid-19-pandemicon-
patients-with-cancer-and-cancer-services/
3 https://www.europeancancer.org/2-standard/31-covid-19-resources
4 https://carnallfarrar.com/coronavirus/cancer-post-covid-impact-outcomes-and-next-steps/
5 https://www.hdruk.ac.uk/case-studies/delineating-the-adverse-impacts-of-the-covid-19-pandemicon-
patients-with-cancer-and-cancer-services/
6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506428/
7 Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-
19 pandemic on cancer survival in the UK: a modelling study. . Lancet Oncol. 2020 21(8):1035-1044.
8 Lai AG, Pasea L, Banerjee A, et al. Estimating excess mortality in people with cancer and multimorbidity
in the Covid-19 emergency. Research Gate april 2020 doi: https://doi.org/10.1101/2020.05.27.20083287
9 https://www.who.int/news/item/15-07-2020-who-and-unicef-warn-of-a-decline-in-vaccinations-during-
covid-19
10 According to the French Society of Radiology, the number of breast cancer screening examinations performed
in women aged 50-74 went, for regions Ile-de-France and Hauts-de-France alone, from 23000
between mid-March and May to zero during the lockdown.
11 According to the Belgian Foundation against cancer, there has been a 48% decrease in breast cancer
screening examinations from April 2019 to April 2020.
12 Loveday C, Sud A, Jones ME, et al. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait
colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study. Gut. 2020 27:
-2020-321650
13 According to the French public Health Insurance Fund, analysed colorectal cancer screening tests have
dropped from 75000 to 80000 per week in the beginning of 2020 to less than 5000 due to lockdown
measures, leading to several hundreds of thousands of missing tests overall.
14 https://cancerworld.net/spotlight-on/unexpected-consequences-of-the-covid-19-pandemics-
on-cancer-patients/
15 Regional Cancer Center Sweden. Deferred cancer care – comparison of the number of newly registered
cancer cases during the covid-19 pandemic 2020 and the corresponding period 2019. 27-09-2020
16 Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the Covid-19 epidemic
in the Netherlands. Lancet Oncol 2020; 21:750-751.
17 Kankerregister. Strong decline in new cancer diagnoses in April due to corona crisis in Belgium. 9-28-
2020. www.kankerregister.org. Accessed: October 2nd 2020
18 French cancer centres report a 20-25% drop on cancer diagnoses during the COVID-19 lockdown
19 https://globalsurg.org/covidsurg/
20 Iezzi R, Valente I, Cina A et al. Longitudinal study of interventional radiology activity in a large metropolitan
Italian tertiary care hospital: how the COVID-19 pandemic emergency has changed our activity.
European Radiology (2020) 30:6940–6949
21 https://epha.org/covid-19-health-inequalities-and-the-challenges-of-cancer-nursing/
22 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153515/
23 Košir U, Loades M, Wild J, et al. The impact of COVID-19 on the cancer care of adolescents and young
adults and their well-being: Results from an online survey conducted in the early stages of the pandemic.
Cancer. 2020 Jul 22;10.1002/cncr.33098
24 Gebbia V, Piazza D, Valerio MR, et al. Patients With Cancer and COVID-19: A WhatsApp Messenger-Based
Survey of Patients’ Queries, Needs, Fears, and Actions Taken. JCO Glob Oncol. 2020 May;6:722-729.
25 https://esmoopen.bmj.com/content/5/3/e000662
26 https://journals.lww.com/hemasphere/fulltext/2020/04000/reducing_bureaucracy_in_clinical_research__
a_call.5.aspx
27 Iezzi R, Valente I, Cina A et al. Longitudinal study of interventional radiology activity in a large metropolitan
Italian tertiary care hospital: how the COVID-19 pandemic emergency has changed our activity. European
Radiology (2020) 30:6940–6949
28 Battisti NML, Misland AL, Cooper L, et al. Adapting care for older cancer patients during the COVID-19 pandemic:
Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working
Group. J Geriatr Oncol. 2020 Nov;11(8):1190-1198. doi: 10.1016/j.jgo.2020.07.008.
29 Vrdoljak E, Sullivan R, Lawler M. Cancer and coronavirus disease 2019; how do we manage cancer optimally
through a public health crisis? Eur J Cancer. 2020; 132:98-99.
30 Yu J, Ouyang W, Chua MLK, et al SARS-CoV-2 transmission in patient with cancer at a tertiary care hospital
in Wuhan, China. JAMA Oncol 2020; 6:1108.
31 Liang W, Guan W, Chen R. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Lancet Oncol 2020;21:335-337.
32 Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-
19 in Italy. JAMA 2020 ;323:1775-1776.
33 Kamal S, Tagliamento M, Lambertini M, et al. Mortality in patients with cancer and COVID-19: a systematic
review and pooled analysis of 52 studies. Eur J Cancer 2020; 139: 43-50.
34 Crul M, Bosnak A, Astier A, et al. The effect of COVID-19 on oncology pharmacy services. Results of a three
month long weekly global survey. Eur J Onc Pharm 2020
35 https://www.europarl.europa.eu/doceo/document/TA-9-2020-0228_EN.pdf
36 https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/the-impact-of-covid-
19-on-oncology-professionals-initial-results-of-the-esmo-resilience-task-force-survey-collaboration
37 https://www.esmo.org/newsroom/press-office/esmo2020-covid-pandemic-halts-cancer-care-oncologist-
wellbeing
38 https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30194-1/fulltext
39 Loveday C, Sud A, Jones ME, Broggio J, Scott S, Gronthound F, Torr B, Garrett A, Nicol DL, Jhanji S, Boyce SA,
Williams M, Barry C, Riboli E, Kipps E, McFerran E, Muller DC, Lyratzopoulos G, Lawler M, Abulafi M, Houlston RS,
Turnbull CPrioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral
pathway during the COVID-19 pandemic: a UK modelling study. Gut. 2020 27: -2020-321650
40 Lai AG, Pasea L, Banerjee A, et al. Estimating excess mortality in people with cancer and multimorbidity in
the Covid-19 emergency. Research Gate april 2020 doi: https://doi.org/10.1101/2020.05.27.20083287
41 Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-
19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 21(8):1035-1044.
42 https://www.europeactive.eu/news/european-parliament-calls-european-health-union
43 https://www.who.int/news/item/19-08-2020-world-health-assembly-adopts-global-strategy-to-accelerate-
cervical-cancer-elimination
